First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study.
Hideo-Kajita A., Garcia-Garcia H.M., Haude M., Joner M., Koolen J., Ince H., Abizaid A., Toelg R., Lemos P.A., von Birgelen C. et al., 2019/05. Cardiovascular revascularization medicine, 20 (5) pp. 392-398. Peer-reviewed.
ici le détail